2020, Clinic, Electronics and Telehealth

Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall

Physician's Weekly

JUNE 17, 2025

TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D., Vinod Rao, M.D.,

Telehealth

Telehealth Relationship Hospital Appointment

Tobacco Use Screening In Community-Based Primary Care Clinics By Visit Modality During The Covid-19 Pandemic [Smoking cessation]

Annals of Family Medicine

NOVEMBER 20, 2024

Context: Primary care delivery was significantly impacted by COVID-19, with rapid deployment of telehealth after the United States’ national public health emergency (PHE) declaration in March 2020. In the years following the PHE, rates of screening for tobacco use decreased, particularly during telehealth visits.

Primary Care

Primary Care Screening Telehealth Community

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

FDA Law Blog

MAY 4, 2023

Cato — On May 2nd, FDA released a new draft guidance with recommendations for decentralized clinical trials (DCTs) for drugs, biologics, and devices. In a DCT, trial-related activities may occur in trial participants’ homes, at local health care providers’ offices, or in local clinical laboratories.

Clinic

Clinic Telehealth Provider Electronics

Primary Care Digest

Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall

Tobacco Use Screening In Community-Based Primary Care Clinics By Visit Modality During The Covid-19 Pandemic [Smoking cessation]

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

Stay Connected